Rockbridge Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,629
Closed -$133K 487
2023
Q4
$133K Buy
+4,629
New +$140K 0.02% 149
2023
Q3
Sell
-6,102
Closed -$224K 110
2023
Q2
$224K Buy
6,102
+103
+2% +$4.01K 0.04% 101
2023
Q1
$245K Sell
5,999
-595
-9% -$25.7K 0.05% 95
2022
Q4
$338K Sell
6,594
-698
-10% -$33.5K 0.07% 83
2022
Q3
$319K Buy
7,292
+754
+12% +$36.6K 0.08% 78
2022
Q2
$343K Sell
6,538
-2,725
-29% -$139K 0.07% 77
2022
Q1
$478K Buy
9,263
+2,343
+34% +$122K 0.07% 103
2021
Q4
$409K Buy
6,920
+1,168
+20% +$57.9K 0.06% 117
2021
Q3
$247K Buy
5,752
+285
+5% +$12.6K 0.04% 128
2021
Q2
$214K Buy
5,467
+69
+1% +$2.68K 0.04% 140
2021
Q1
$196K Sell
5,398
-4,946
-48% -$176K 0.04% 139
2020
Q4
$381K Sell
10,344
-506
-5% -$18.6K 0.08% 106
2020
Q3
$378K Buy
10,850
+280
+3% +$9.82K 0.09% 96
2020
Q2
$328K Buy
+10,570
New +$359K 0.09% 96

Other funds holding PFE

Rockbridge Investment Management's PFE Position: Q1 2024 in Review

Rockbridge Investment Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 4,629 shares — an estimated $133K sold.

Rockbridge Investment Management first reported a position in PFE in Q2 2020 and held it in 14 quarters. The position peaked at $478K in Q1 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Rockbridge Investment Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Rockbridge Investment Management sold 4,629 Pfizer shares in Q1 2024, an estimated $133K.
  • Rockbridge Investment Management first reported a position in Pfizer in Q2 2020 and held it in 14 quarters.
  • Rockbridge Investment Management's Pfizer position peaked at $478K in Q1 2022.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.